Fig. 4From: Extracellular vesicles derived from mesenchymal stem cells — a novel therapeutic tool in infectious diseasesMSC-EVs expressing ACE2 receptor competitively binds to SARS-CoV-2 and prevents the binding of SARS-CoV-2 to AT2 cellsBack to article page